Is A Fall Imminent For Endo Pharmaceuticals Stock After Its Recent 58% Rise?
- Thursday, November 11, 2021, 7:30
- Market
- Add a comment
The stock price of Endo Pharmaceuticals has seen a stellar 58% rise over the last month, while it is up 31% in a week. There are a couple of factors that fueled this growth. First, the company recently reported its Q3 results with revenue of $772 million, well above the consensus estimate…
About the Author
admin123 has written 23519 stories on this site.
